课题基金 / 基金详情

项目摘要

项目成果

Stephanie M Karst的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Human noroviruses in the Caliciviridae family are the major cause of non-bacterial epidemic gastroenteritis worldwide. Primary human norovirus infection does not elicit lasting protective immunity, a fact that could greatly affect the efficacy of vaccination strategies. Our long term goal is to elucidate the mechanisms by which noroviruses avoid the induction of protective immunity, ultimately translating this knowledge into successful vaccination approaches. Little is known regarding the pathogenesis of human noroviruses or the immune responses that control them because there has previously been no small animal model or cell culture system of infection. Data from our laboratory has defined the first small animal model of norovirus infection: We discovered the first murine norovirus (MNV), MNV-1, and demonstrated its cultivation in macrophages and dendritic cells in vitro. We have now used these unique models to examine norovirus pathogenesis and immunity. We have determined that MNV-1 is infectious orally and induces gastroenteritis, confirming the utility of this virus as a model to study human norovirus pathogenesis. Importantly, we have also determined that primary MNV-1 infection fails to afford protection to re-challenge with homologous virus. Thus, MNV-1 represents a valuable model with which to dissect the pathophysiological basis for the lack of lasting protection to human norovirus infection. Our specific hypothesis is that norovirus infection fails to induce protective mucosal immunity because the virus infects mucosal dendritic cells and prevents their full activation. Specifically, we will determine whether MNV-1 infection directly or indirectly inhibits dendritic cell activation and whether MNV-1 infection stimulates regulatory T cells. Our ultimate goal is to understand how these effects on mucosal dendritic cells prevent their stimulation of protective norovirus immunity and to translate this information into effective vaccine design.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Regulation of Norovirus Virulence by the VP1 Protruding Domain Correlates with B Cell Infection Efficiency.
VP1 突出结构域对诺如病毒毒力的调节与 B 细胞感染效率相关。
DOI: 10.1128/jvi.02880-15
发表时间: 2015
期刊: Journal of virology
影响因子: 5.4
作者: [Zhu,Shu, Watanabe,Makiko, Kirkpatrick,Ericka, Murray,AkilahB, Sok,Ryneth, Karst,StephanieM]
通讯作者: Karst,StephanieM
DOI: 10.1371/journal.ppat.1003592
发表时间: 2013
期刊: PLoS pathogens
影响因子: 6.7
作者: [Zhu S, Regev D, Watanabe M, Hickman D, Moussatche N, Jesus DM, Kahan SM, Napthine S, Brierley I, Hunter RN 3rd, Devabhaktuni D, Jones MK, Karst SM]
通讯作者: Karst SM
Elucidation of Pathogenic Mechanisms underlying Norovirus Diarrhea
  • 批准号:
    10624395
  • 项目类别:
  • 资助金额:
    $60.4万
  • 财政年份:
    2021
  • 负责人:
    Stephanie M Karst
  • 依托单位:
Elucidation of Pathogenic Mechanisms underlying Norovirus Diarrhea
  • 批准号:
    10413248
  • 项目类别:
  • 资助金额:
    $60.4万
  • 财政年份:
    2021
  • 负责人:
    Stephanie M Karst
  • 依托单位:
Elucidation of Pathogenic Mechanisms underlying Norovirus Diarrhea
  • 批准号:
    10277083
  • 项目类别:
  • 资助金额:
    $60.4万
  • 财政年份:
    2021
  • 负责人:
    Stephanie M Karst
  • 依托单位:
Suppression of Enteric Norovirus Infection by Microbiota-Regulated Bile Acids
  • 批准号:
    10061535
  • 项目类别:
  • 资助金额:
    $53.74万
  • 财政年份:
    2018
  • 负责人:
    Stephanie M Karst
  • 依托单位:
海外基金